Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
BMC Cancer|February 17, 2016
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplificationJieyi Wang, Liliane Goetsch, Lora Tucker, et al.
Nature Biomedical Engineering|December 10, 2025
A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunityChangrui Yang, Shanni Guo, Kaiyan Ye, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2007
Lead optimization of methionine aminopeptidase-2 (MetAP2) inhibitors containing sulfonamides of 5,6-disubstituted anthranilic acidsGary T Wang, Robert A Mantei, Megumi Kawai, et al.
Protein & Cell|June 7, 2017
Potent and conditional redirected T cell killing of tumor cells using Half DVD-IgPhilip D Bardwell, Matthew M Staron, Junjian Liu, et al.
Nature Communications|April 20, 2022
Gut microbiota-bile acid crosstalk contributes to the rebound weight gain after calorie restriction in miceMengci Li, Shouli Wang, Yitao Li, et al.
BMC Cancer|September 8, 2009
Reversal of oncogene transformation and suppression of tumor growth by the novel IGF1R kinase inhibitor A-928605William N Pappano, Paul M Jung, Jonathan A Meulbroek, et al.
Cell Metabolism|August 17, 2023
Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axisJunliang Kuang, Jieyi Wang, Yitao Li, et al.
Cancer Research|November 25, 2003
Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2Jieyi Wang, George S Sheppard, Pingping Lou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 16, 2026
Sex-Specific Regulation of Glycemic Homeostasis by Theabrownin from Pu-erh TeaYang Li, Junliang Kuang, Dan Zheng, et al.
Pageof 8